ArticleThe Journal of infectious diseases2023

A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.

Nicholas P Wayham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.